Acadian Asset Management
IMCR icon

Acadian Asset Management’s Immunocore IMCR Stock Holding History

Acadian Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.4M Buy
1,209,894
+708,803
+141% +$21M 0.05% 300
2026
Q1 		$15.1M Buy
501,091
+39,261
+9% +$1.27M 0.02% 434
2025
Q4 		$16M Buy
461,830
+262,333
+131% +$9.26M 0.03% 370
2025
Q3 		$7.24M Buy
199,497
+108,699
+120% +$3.69M 0.01% 549
2025
Q2 		$2.84M Buy
90,798
+72,355
+392% +$2.25M 0.01% 733
2025
Q1 		$546K Sell
18,443
-22,108
-55% -$663K ﹤0.01% 1064
2024
Q4 		$1.19M Buy
40,551
+39,691
+4,615% +$1.25M ﹤0.01% 890
2024
Q3 		$26K Buy
+860
New +$31.3K ﹤0.01% 1937
2023
Q3 		– Sell
-6
Closed – – 1733
2023
Q2 		$0 Sell
6
-63,457
-100% -$3.62M ﹤0.01% 1816
2023
Q1 		$3.13M Sell
63,463
-206,422
-76% -$11.6M 0.01% 586
2022
Q4 		$15.4M Buy
269,885
+85,420
+46% +$4.81M 0.08% 217
2022
Q3 		$8.65M Buy
+184,465
New +$8.79M 0.05% 293

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Acadian Asset Management's IMCR Position: Q2 2026 in Review

Acadian Asset Management increased its Immunocore (IMCR) stake by 141% in Q2 2026, buying an estimated $21M and bringing the position to 1,209,894 shares worth $38.4M. The position accounts for 0.05% of the portfolio, ranked #300.

Acadian Asset Management first reported a position in IMCR in Q3 2022 and has held it in 12 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Acadian Asset Management held 1,209,894 shares of Immunocore worth $38.4M as of Q2 2026.
  • Acadian Asset Management bought 708,803 Immunocore shares in Q2 2026, an estimated $21M.
  • Immunocore made up 0.05% of Acadian Asset Management's portfolio in Q2 2026, its #300 holding.
  • Acadian Asset Management first reported a position in Immunocore in Q3 2022 and has held it in 12 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.